No burp syndrome, medically known as retrograde cricopharyngeal dysfunction (R-CPD), is a condition in which a person is unable to burp normally. It can cause significant abdominal bloating, chest or throat pressure, gurgling noises and excessive flatulence.
Although R-CPD has only been recognised in the medical literature relatively recently, it appears to be an established clinical syndrome and is increasingly diagnosed by ENT and upper gastrointestinal specialists.
The good news is that R-CPD is highly treatable, with botulinum toxin (Botox) injection into the cricopharyngeus muscle providing symptom relief for the majority of patients.
What is no burp syndrome?
The defining feature of R-CPD is the inability to belch. Most patients also have several associated symptoms.
A systematic review of published cases found that inability to belch was present in essentially all patients, while abdominal bloating and gurgling noises were also very common. Excessive flatulence and chest or abdominal discomfort are frequently reported.
Typical symptoms include:
- Inability or marked difficulty burping
- Gurgling or croaking noises from the throat or chest
- Abdominal bloating and distension
- Pressure or discomfort in the chest or upper abdomen
- Excessive flatulence
- Difficulty tolerating carbonated drinks
- In some patients, difficulty vomiting
When does R-CPD start?
Many people with no burp syndrome report that they have never been able to burp normally. It may therefore begin in childhood or adolescence, although some patients only recognise the problem when symptoms become more troublesome later in life.
The condition can remain undiagnosed for many years because the symptoms may be attributed to reflux, irritable bowel syndrome, functional dyspepsia or simply “excess wind”.
R-CPD has also been described in adolescents. In a small paediatric series, patients presented with inability to burp and characteristic involuntary throat noises, with abnormalities demonstrated during specialised oesophageal testing.
Why does the gurgling happen?
The characteristic gurgling or croaking noise is one of the clues to the diagnosis.
We all swallow small amounts of air during eating, drinking and talking. Gas can also move upwards from the stomach into the oesophagus. Normally, when gas needs to escape, the upper oesophageal sphincter briefly relaxes, allowing the gas to pass upwards and out through the mouth as a belch.
In R-CPD, the upper oesophageal sphincter appears not to relax appropriately during this retrograde movement of gas. The gas therefore becomes trapped in the oesophagus and can move backwards and forwards, producing the distinctive bubbling, gurgling or croaking sounds.
Recent high-resolution impedance manometry studies have provided physiological evidence for this mechanism. During a sparkling-water challenge, patients with R-CPD had higher upper oesophageal sphincter pressures, incomplete clearance of air and oscillation of air within the oesophagus. Following botulinum toxin treatment, sphincter pressure fell and air clearance improved.
What normally happens when we burp?
The cricopharyngeus muscle forms a major component of the upper oesophageal sphincter. It normally remains contracted between swallows, helping to protect the airway and prevent unwanted entry of air into the oesophagus.
During swallowing, the muscle relaxes to allow food and liquid to pass from the throat into the oesophagus.
Belching requires another carefully coordinated physiological response. Gas moving upwards through the oesophagus needs to be allowed through the upper oesophageal sphincter and into the pharynx, from where it can escape through the mouth.
The leading theory in R-CPD is therefore that the cricopharyngeus fails to relax appropriately during retrograde gas movement, despite being capable of functioning during swallowing. This is why the condition is termed retrograde cricopharyngeal dysfunction.
The exact neurological mechanism responsible for this abnormal reflex remains uncertain.
How is R-CPD diagnosed?
Diagnosis is currently based primarily on the clinical history and characteristic symptoms. There is not yet a universally accepted single diagnostic test or internationally agreed diagnostic criteria.
The combination of lifelong or longstanding inability to burp, gurgling noises, bloating and excessive flatulence is particularly suggestive.
Investigations such as endoscopy, contrast studies or conventional swallowing assessments may be appropriate to exclude other disorders when the clinical history warrants them, but they do not necessarily demonstrate R-CPD.
A particularly promising investigation is high-resolution impedance manometry (HRIM) with a belch-provocation test, such as rapidly drinking sparkling water. Recent research has demonstrated measurable differences in upper oesophageal sphincter behaviour between patients with R-CPD and control subjects.
At present, however, HRIM is not required in every patient and its role in routine diagnosis continues to evolve.
Botox treatment for no burp syndrome
The established treatment for R-CPD is botulinum toxin injection into the cricopharyngeus muscle.
Botulinum toxin temporarily weakens the muscle and allows the upper oesophageal sphincter to open more readily during retrograde gas movement. The aim is to restore the ability to burp and relieve the accumulation of gas responsible for many of the symptoms.
Treatment may be performed under direct endoscopic visualisation, or by other approaches depending on the clinician and clinical setting.
A 2025 meta-analysis involving 699 patients found 91.5% early symptom relief within 1–4 weeks of treatment. Sustained symptom relief, assessed over follow-up periods ranging from 3 to 29 months, was approximately 80%.
A separate systematic review of 637 patients found that approximately 87% improved following their initial botulinum toxin treatment.
These are encouraging results, although it is important to recognise that most published studies are case series rather than randomised controlled trials.
Will I need another Botox injection?
Not necessarily.
One of the intriguing features of R-CPD treatment is that Botox can have an effect that outlasts its pharmacological action. The theory is that once the cricopharyngeus has been temporarily relaxed, patients may acquire the ability to belch and subsequently retain this function after the Botox has worn off.
However, symptoms can recur in some patients.
The systematic review literature suggests that when symptoms recur or fail to resolve after the first injection, repeat botulinum toxin treatment is usually worthwhile. Approximately 80% of patients receiving a subsequent injection achieved symptom resolution in one systematic review.
A 2025 prospective study of 198 patients also found that repeat injections were effective in patients whose symptoms recurred.
For the small number of patients who remain significantly symptomatic despite repeated Botox treatment, cricopharyngeal myotomy may be considered in selected cases.
The outlook for patients with R-CPD
No burp syndrome can have a surprisingly large impact on quality of life, particularly when bloating, chest pressure and constant gurgling interfere with eating, social activities and exercise.
The recognition of retrograde cricopharyngeal dysfunction (R-CPD) has provided an explanation for a group of patients who previously had few treatment options.
Although research into the condition is still developing, current evidence suggests that cricopharyngeal Botox injection is an effective treatment for the majority of patients, with approximately nine out of ten experiencing early improvement and around eight out of ten maintaining benefit during available longer-term follow-up.
For someone who has never been able to burp, particularly when accompanied by gurgling, bloating and excessive flatulence, R-CPD should be considered as a potential diagnosis.